FR20C1020I1 - PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT

Info

Publication number: FR20C1020I1
Authority: FR; France
Prior art keywords: pharmaceutical composition; composition containing; contraceptive kit; containing drospirenone; drospirenone
Prior art date: 2010-06-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR20C1020C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Laboratorios Leon Farma SA

Original Assignee

Laboratorios Leon Farma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-29

Filing date

2020-06-11

Publication date

2020-08-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42671710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR20C1020(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2020-06-11 Application filed by Laboratorios Leon Farma SA filed Critical Laboratorios Leon Farma SA

2020-08-07 Publication of FR20C1020I1 publication Critical patent/FR20C1020I1/en

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

FR20C1020C 2010-06-29 2020-06-11 PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT Active FR20C1020I1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP10305708		2010-06-29
US36839610P	2010-07-28	2010-07-28
EP11727985.1A EP2588114B1 (en)	2010-06-29	2011-06-28	Pharmaceutical composition comprising drospirenone and contraceptive kit
PCT/EP2011/060795 WO2012000981A1 (en)	2010-06-29	2011-06-28	Pharmaceutical composition comprising drospirenone and contraceptive kit

Publications (1)

Publication Number	Publication Date
FR20C1020I1 true FR20C1020I1 (en)	2020-08-07

Family

ID=42671710

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FR20C1020C Active FR20C1020I1 (en)	2010-06-29	2020-06-11	PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT
FR22C1031C Active FR22C1031I2 (en)	2010-06-29	2022-06-23	PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
FR22C1031C Active FR22C1031I2 (en)	2010-06-29	2022-06-23	PHARMACEUTICAL COMPOSITION COMPRISING DROSPIRENONE FOR USE AS A CONTRACEPTIVE

Country Status (25)

Country	Link
US (7)	US11452695B2 (en)
EP (3)	EP2588114B1 (en)
JP (1)	JP5810159B2 (en)
KR (3)	KR20130048227A (en)
AR (1)	AR081670A1 (en)
BR (1)	BR112012033391B1 (en)
CA (3)	CA3061421C (en)
CY (2)	CY1122544T1 (en)
DK (1)	DK3632448T3 (en)
EA (1)	EA028680B1 (en)
ES (1)	ES2908657T3 (en)
FR (2)	FR20C1020I1 (en)
HR (1)	HRP20220332T1 (en)
HU (3)	HUE058176T2 (en)
LT (2)	LT3632448T (en)
NO (2)	NO2020015I1 (en)
NZ (1)	NZ605176A (en)
PE (2)	PE20130780A1 (en)
PH (1)	PH12012502499A1 (en)
PL (2)	PL3632448T3 (en)
PT (1)	PT3632448T (en)
RS (2)	RS63027B1 (en)
SI (2)	SI3632448T1 (en)
SM (2)	SMT202200129T1 (en)
WO (1)	WO2012000981A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR081670A1 (en)	2010-06-29	2012-10-10	Leon Farma Sa Lab	PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
SI3310346T1 (en)	2015-06-18	2021-07-30	Estetra Sprl	Orodispersible tablet containing estetrol
LT3106148T (en)	2015-06-18	2018-06-25	Mithra Pharmaceuticals S.A.	Orodispersible dosage unit containing an estetrol component
US11147771B2 (en)	2015-06-18	2021-10-19	Estetra Sprl	Orodispersible dosage unit containing an estetrol component
ES2877186T3 (en)	2015-06-18	2021-11-16	Estetra Sprl	Orodispersible tablet containing estetrol
EP3108889A1 (en)	2015-06-23	2016-12-28	Philippe Perrin	Drospirenone-based contraceptive for a female patient affected with excess weight
RS65196B1 (en) *	2015-06-23	2024-03-29	Laboratorios Leon Farma Sa	Drospirenone-based contraceptive for a female patient affected with excess weight
KR102712911B1 (en)	2016-08-05	2024-10-04	에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼	Method for the management of dysmenorrhea and menstrual pain
TWI801561B (en)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	Compounds and their uses for alleviating menopause-associated symptoms
JOP20200260A1 (en)	2018-04-19	2019-10-19	Estetra Sprl	Compounds and their uses for alleviating menopause-associated symptoms
EP4134082A1 (en)	2021-08-12	2023-02-15	Chemo Research, S.L.	Method for treating endometriosis and providing effective contraception
WO2023152658A1 (en)	2022-02-10	2023-08-17	Lupin Limited	Slow release drospirenone tablet composition
WO2023165988A1 (en)	2022-03-01	2023-09-07	Chemo Research, S.L.	Chewable oral contraceptive

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652761C2 (en)	1976-11-16	1985-11-21	Schering AG, 1000 Berlin und 4709 Bergkamen	15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them
DE3022337A1 (en)	1980-06-11	1982-01-07	Schering Ag Berlin Und Bergkamen, 1000 Berlin	Compsns. for contraception or treatment of gynaecological disorders - contg. 6 beta, 7 beta; 15 delta, 16 beta-di:methylene-3-oxo-4-androstene-17(beta-1')-spiro-5'-per:hyd- ro-furan-2'-one
JP3282731B2 (en)	1990-06-15	2002-05-20	メルクエンドカムパニーインコーポレーテッド	Crystallization method for improving crystal structure and size
GB2256648B (en)	1991-05-29	1995-08-30	Colorcon Ltd	Wax polish composition
DE19633685C1 (en)	1996-08-12	1997-10-09	Schering Ag	Production of drospirenone useful as steroidal agent
US6787531B1 (en)	1999-08-31	2004-09-07	Schering Ag	Pharmaceutical composition for use as a contraceptive
BR0014159A (en)	1999-08-31	2002-05-07	Schering Ag	Pharmaceutical combination of ethinyl estradiol and drospirenone for use as a contraceptive
DK1611892T3 (en)	2000-01-18	2009-11-02	Bayer Schering Pharma Ag	Pharmaceutical compositions containing drospirenone
US20020132801A1 (en)	2001-01-11	2002-09-19	Schering Aktiengesellschaft	Drospirenone for hormone replacement therapy
US20040087563A1 (en)	2002-11-05	2004-05-06	Siegfried Mayerhofer	Hormone replacement therapy with cardiovascular protection using antialdosteronic progestins
US7786101B2 (en)	2002-11-05	2010-08-31	Bayer Schering Pharma Ag	Cardiovascular protection using anti-aldosteronic progestins
MY142989A (en)	2004-03-10	2011-02-14	Bayer Schering Pharma Ag	Stabilised supersaturated solids of lipophilic drugs
US20050220825A1 (en)	2004-03-10	2005-10-06	Adrian Funke	Molecular dispersions of drospirenone
ATE476961T1 (en)	2004-03-10	2010-08-15	Bayer Schering Pharma Ag	LIQUID COMPOSITIONS AS MICRO-EMULSION PRECONCENTRATE WITH MOLECULARLY DISPERSED DROSPIRENONE
MY151322A (en)	2004-04-30	2014-05-15	Bayer Ip Gmbh	Management of breakthrough bleeding in extended hormonal contraceptive regimens
TW200603813A (en)	2004-07-07	2006-02-01	Wyeth Corp	Cyclic progestin regimens and kits
EP1625849A1 (en)	2004-08-09	2006-02-15	Liconsa, Liberacion Controlada de Sustancias Activas, S.A.	Pharmaceutical composition comprising drospirenone and ethynylestradiol
ITMI20042338A1 (en)	2004-12-06	2005-03-06	Ind Chimica Srl	PROCESS FOR THE PREPARATION OF DROSPIRENONE
US20060293295A1 (en)	2005-05-13	2006-12-28	Kai Strothmann	Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate
US8475838B2 (en)	2005-06-03	2013-07-02	Sandoz Ag	Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
TW200727920A (en)	2005-06-21	2007-08-01	Organon Nv	New regimens for oral monophasic contraceptives
SI1746101T2 (en)	2005-07-21	2014-09-30	Bayer Pharma Aktiengesellschaft	Process for the production of Oxo-pregn-4-en-21,17-carbolactonen by metal free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes
CN101489563A (en)	2006-07-06	2009-07-22	拜耳先灵医药股份有限公司	Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
WO2008031631A2 (en) *	2006-09-16	2008-03-20	Bayer Schering Pharma Aktiengesellschaft	Oral modified release formulations
TW200930343A (en)	2007-09-21	2009-07-16	Organon Nv	Drug delivery system
BRPI0908231A2 (en)	2008-02-13	2015-07-21	Bayer Schering Pharma Akltiengesellschaft	Stabilizing drug release system
WO2009138224A1 (en) *	2008-05-14	2009-11-19	Helm Ag	Pharmaceutical composition comprising drospirenone
DE102008037025C5 (en)	2008-08-08	2016-07-07	Jesalis Pharma Gmbh	Process for the preparation of crystalline drug microparticles or a solid state drug particle form
TW201008569A (en) *	2008-08-08	2010-03-01	Bayer Schering Pharma Ag	Progestin-containing drug delivery system
AR081670A1 (en) *	2010-06-29	2012-10-10	Leon Farma Sa Lab	PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND ANTI-ECONCEPTIVE KIT
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

2011
- 2011-06-27 AR ARP110102229A patent/AR081670A1/en not_active Application Discontinuation
- 2011-06-28 KR KR1020137001350A patent/KR20130048227A/en active Search and Examination
- 2011-06-28 CA CA3061421A patent/CA3061421C/en active Active
- 2011-06-28 CA CA2803721A patent/CA2803721C/en active Active
- 2011-06-28 JP JP2013517245A patent/JP5810159B2/en active Active
- 2011-06-28 RS RS20220179A patent/RS63027B1/en unknown
- 2011-06-28 RS RS20200081A patent/RS59826B1/en unknown
- 2011-06-28 BR BR112012033391-7A patent/BR112012033391B1/en active IP Right Grant
- 2011-06-28 HR HRP20220332TT patent/HRP20220332T1/en unknown
- 2011-06-28 WO PCT/EP2011/060795 patent/WO2012000981A1/en active Application Filing
- 2011-06-28 EP EP11727985.1A patent/EP2588114B1/en active Active
- 2011-06-28 PH PH1/2012/502499A patent/PH12012502499A1/en unknown
- 2011-06-28 PE PE2012002518A patent/PE20130780A1/en active IP Right Grant
- 2011-06-28 EP EP19209672.5A patent/EP3632448B1/en active Active
- 2011-06-28 KR KR1020217002806A patent/KR102539030B1/en active Active
- 2011-06-28 PE PE2016002187A patent/PE20161410A1/en unknown
- 2011-06-28 ES ES19209672T patent/ES2908657T3/en active Active
- 2011-06-28 SI SI201132044T patent/SI3632448T1/en unknown
- 2011-06-28 DK DK19209672.5T patent/DK3632448T3/en active
- 2011-06-28 EA EA201291372A patent/EA028680B1/en unknown
- 2011-06-28 LT LTEP19209672.5T patent/LT3632448T/en unknown
- 2011-06-28 EP EP22150746.0A patent/EP4056186A1/en active Pending
- 2011-06-28 SM SM20220129T patent/SMT202200129T1/en unknown
- 2011-06-28 SI SI201131838T patent/SI2588114T1/en unknown
- 2011-06-28 KR KR1020177019333A patent/KR102164693B1/en active Active
- 2011-06-28 SM SM20200063T patent/SMT202000063T1/en unknown
- 2011-06-28 PL PL19209672T patent/PL3632448T3/en unknown
- 2011-06-28 HU HUE19209672A patent/HUE058176T2/en unknown
- 2011-06-28 PT PT192096725T patent/PT3632448T/en unknown
- 2011-06-28 PL PL11727985T patent/PL2588114T3/en unknown
- 2011-06-28 CA CA3003062A patent/CA3003062C/en active Active
- 2011-06-28 NZ NZ605176A patent/NZ605176A/en unknown
2020
- 2020-02-03 CY CY20201100088T patent/CY1122544T1/en unknown
- 2020-06-11 FR FR20C1020C patent/FR20C1020I1/en active Active
- 2020-06-11 NO NO2020015C patent/NO2020015I1/en unknown
- 2020-06-11 HU HUS2000016C patent/HUS2000016I1/en unknown
2022
- 2022-03-10 CY CY20221100198T patent/CY1125061T1/en unknown
- 2022-04-11 US US17/717,550 patent/US11452695B2/en active Active
- 2022-05-10 HU HUS2200018C patent/HUS2200018I1/en unknown
- 2022-06-22 LT LTPA2022513C patent/LTPA2022513I1/lt unknown
- 2022-06-23 FR FR22C1031C patent/FR22C1031I2/en active Active
- 2022-06-29 US US17/853,623 patent/US11478487B1/en active Active
- 2022-06-30 US US17/855,432 patent/US11491113B1/en active Active
- 2022-07-01 US US17/856,605 patent/US11504334B2/en active Active
- 2022-07-11 NO NO2022030C patent/NO2022030I1/en unknown
- 2022-10-17 US US17/967,767 patent/US12090231B2/en active Active
2023
- 2023-08-04 US US18/365,877 patent/US11951213B2/en active Active
2024
- 2024-07-05 US US18/765,167 patent/US20240366512A1/en active Pending

Also Published As

Publication number	Publication date
CA3003062A1 (en)	2012-01-05
PL2588114T3 (en)	2020-05-18
HUS2000016I1 (en)	2020-07-28
AU2011273605B2 (en)	2016-05-26
CA2803721C (en)	2018-06-12
SI3632448T1 (en)	2022-04-29
US12090231B2 (en)	2024-09-17
FR22C1031I2 (en)	2023-12-22
BR112012033391B1 (en)	2020-02-27
HRP20220332T1 (en)	2022-05-13
KR102539030B1 (en)	2023-05-31
US20240366512A1 (en)	2024-11-07
CA2803721A1 (en)	2012-01-05
US11504334B2 (en)	2022-11-22
CA3003062C (en)	2019-12-31
CA3061421A1 (en)	2012-01-05
EP2588114A1 (en)	2013-05-08
EP3632448A1 (en)	2020-04-08
WO2012000981A1 (en)	2012-01-05
SMT202000063T1 (en)	2020-03-13
EA028680B1 (en)	2017-12-29
JP2013529665A (en)	2013-07-22
US11452695B2 (en)	2022-09-27
LT3632448T (en)	2022-03-25
RS63027B1 (en)	2022-04-29
KR20170085604A (en)	2017-07-24
PE20161410A1 (en)	2017-01-10
NZ605176A (en)	2015-02-27
PT3632448T (en)	2022-03-07
HUS2200018I1 (en)	2022-06-28
EP3632448B1 (en)	2022-01-12
CY1122544T1 (en)	2021-01-27
RS59826B1 (en)	2020-02-28
NO2020015I1 (en)	2020-06-11
EP2588114B1 (en)	2019-12-25
SI2588114T1 (en)	2020-07-31
CA3061421C (en)	2021-06-01
PH12012502499A1 (en)	2013-03-25
EA201291372A1 (en)	2013-06-28
BR112012033391A2 (en)	2016-11-22
HUE058176T2 (en)	2022-07-28
AU2011273605A8 (en)	2016-07-28
BR112012033391A8 (en)	2018-04-17
KR20130048227A (en)	2013-05-09
JP5810159B2 (en)	2015-11-11
US20220241209A1 (en)	2022-08-04
SMT202200129T1 (en)	2022-05-12
DK3632448T3 (en)	2022-02-07
US20230372248A1 (en)	2023-11-23
KR20210013663A (en)	2021-02-04
LTPA2022513I1 (en)	2022-07-11
FR22C1031I1 (en)	2022-09-09
ES2908657T3 (en)	2022-05-03
CY1125061T1 (en)	2023-06-09
KR102164693B1 (en)	2020-10-13
US20220339165A1 (en)	2022-10-27
US11491113B1 (en)	2022-11-08
US11478487B1 (en)	2022-10-25
US20230046871A1 (en)	2023-02-16
US20220339107A1 (en)	2022-10-27
EP4056186A1 (en)	2022-09-14
PL3632448T3 (en)	2022-05-02
AR081670A1 (en)	2012-10-10
AU2011273605A1 (en)	2013-01-17
NO2022030I1 (en)	2022-07-11
US11951213B2 (en)	2024-04-09
US20220339106A1 (en)	2022-10-27
PE20130780A1 (en)	2013-07-06

Publication	Publication Date	Title
FR20C1020I1 (en)	2020-08-07	PHARMACEUTICAL COMPOSITION CONTAINING DROSPIRENONE AND CONTRACEPTIVE KIT
EP2451435A4 (en)	2013-05-29	PHARMACEUTICAL COMPOSITIONS CONTAINING SODIUM THIOSULFATE
IL222738A0 (en)	2012-12-31	Pharmaceutical emulsion composition comprising progestogen
PT2621468T (en)	2017-09-08	PHARMACEUTICAL COMPOSITION OF CARBETOCIN
EP2646006A4 (en)	2014-06-25	PHARMACEUTICAL FORM
FR2948568B1 (en)	2012-08-24	PHARMACEUTICAL FORMULATION
EP2519240A4 (en)	2014-03-26	PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND ROSUVASTATIN
FR2958157B1 (en)	2012-06-29	COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING N-ACETYL-GLUCOSAMINE-6-PHOSPHATE
EP2627173A4 (en)	2014-05-07	PREPARATIONS OF CLEVIDIPINE IN EMULSION CONTAINING ANTIMICROBIAL AGENTS
EP2833879A4 (en)	2016-03-02	KYNURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
EP2642979A4 (en)	2014-09-17	PHARMACEUTICAL COMPOSITION
EP2475649A4 (en)	2013-02-13	INDENONIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
DK2542224T3 (en)	2014-10-20	ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANETEXILATE
EP2421901A4 (en)	2012-10-10	Compositions containing hc ha complex and methods of use thereof
EP2332535A4 (en)	2013-11-27	SOLID PHARMACEUTICAL COMPOSITION
BR112013014189A8 (en)	2018-01-09	pharmaceutical composition, use of a potentiating agent and use of a composition
BRPI1006666A2 (en)	2016-04-19	"pharmaceutical composition and use of a pharmaceutical composition"
BR112013015819A2 (en)	2018-05-29	DNA construction, pharmaceutical composition and use of a DNA construction
BR112013010709A2 (en)	2019-09-24	trans-2-decenoic acid derivative and pharmaceutical agent containing the same
BRPI1006953A2 (en)	2016-04-26	pharmaceutical composition and use of a pharmaceutical composition
EP2666482A4 (en)	2015-01-07	PARTICLE COMPOSITION AND PHARMACEUTICAL COMPOSITION USING THE SAME
EP2279999A4 (en)	2012-10-31	RETINOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
HUE054171T2 (en)	2021-08-30	Pharmaceutical compositions containing paracetamol and methods for their preparation
BR112012016736A2 (en)	2016-12-13	composition, pharmaceutical formulation and use of composition "
FR2940086B1 (en)	2011-03-11	PHARMACEUTICAL FORMULATION OF NANONIZED FENOFIBRATE